A Study to Evaluate Adrixetinib (Q702) in Adults With Active Chronic Graft-Versus-Host Disease

Clinical trial NCT07138196 · RECRUITING

Trial details

NCT number: NCT07138196
Sponsor: Qurient Co., Ltd.
Status: RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

Chronic Graft-Versus-Host Disease

Start date: 2025-12-23
Primary completion: 2029-10-23
Enrollment: 18

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.